Daniel Janse, PhD

Daniel Janse is a Director at Northpond Ventures on the firm’s biotechnologies team. Daniel is a Board Director at Aro Biotherapeutics and Triumvira Immunologics. Previously, Daniel was the Chief Operating Officer and Chief Business Officer at Arbor Biotechnologies, where he led scientific and general operations, business development, program and alliance management, and corporate development and strategy. Prior to Arbor, Daniel served in leadership positions in the U.S. and Europe at Juno Therapeutics, Johnson & Johnson Innovation Center, Inventages Venture Capital, and McKinsey & Company. Additionally, he was a Presidenti